A Program of Research to Evaluate the Impact of Deceased Organ Donation Legislative Reform in Nova Scotia: The LEADDR Program.


Journal

Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 17 07 2020
revised: 05 10 2020
accepted: 07 10 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 19 12 2020
Statut: epublish

Résumé

This is the first time deemed consent, where the entire population of a jurisdiction is considered to have consented for donation unless they have registered otherwise, will be implemented in North America. While relatively common in other regions of the world-notably Western Europe-it is uncertain how this practice will influence deceased donation practices and attitudes in Canada. We describe a Health Canada funded program of research that will evaluate the implementation process and full impact of the deceased organ donation legislation and the health system transformation in Nova Scotia that includes opt-out consent. There is a need to evaluate the impact of these changes to inform not only Nova Scotia and Atlantic Canada, but also other provincial, national, and international stakeholders. We establish a rigorous academic framework that we will use to evaluate this significant health system transformation.

Sections du résumé

BACKGROUND BACKGROUND
This is the first time deemed consent, where the entire population of a jurisdiction is considered to have consented for donation unless they have registered otherwise, will be implemented in North America. While relatively common in other regions of the world-notably Western Europe-it is uncertain how this practice will influence deceased donation practices and attitudes in Canada.
METHODS METHODS
We describe a Health Canada funded program of research that will evaluate the implementation process and full impact of the deceased organ donation legislation and the health system transformation in Nova Scotia that includes opt-out consent.
RESULTS RESULTS
There is a need to evaluate the impact of these changes to inform not only Nova Scotia and Atlantic Canada, but also other provincial, national, and international stakeholders.
CONCLUSIONS CONCLUSIONS
We establish a rigorous academic framework that we will use to evaluate this significant health system transformation.

Identifiants

pubmed: 33335980
doi: 10.1097/TXD.0000000000001093
pmc: PMC7738157
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e641

Informations de copyright

Copyright © 2020 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Health Technol Assess. 2009 May;13(26):iii, ix-xi, 1-95
pubmed: 19422754
Intensive Care Med. 2016 Feb;42(2):264-7
pubmed: 26077047
Anaesthesia. 2020 Sep;75(9):1146-1152
pubmed: 32372409
Can J Anaesth. 2019 Apr;66(4):432-447
pubmed: 30565159
Kidney Int. 2019 Jun;95(6):1453-1460
pubmed: 31010718
Nephrol Dial Transplant. 2012 Jun;27(6):2526-33
pubmed: 22193049
Am J Transplant. 2017 Jun;17(6):1447-1454
pubmed: 28066980
BMC Med. 2014 Sep 24;12:131
pubmed: 25285666
Healthc Manage Forum. 2020 Sep;33(5):210-213
pubmed: 32323580

Auteurs

Matthew J Weiss (MJ)

Transplant Québec, Montréal, QC, Canada.
CHU de Québec-Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Trauma-Emergency-Critical Care Medicine, Université Laval, Québec, QC, Canada.

Kristina Krmpotic (K)

Legacy of Life and Critical Care Organ Donation, Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Critical Care, Dalhousie University, Halifax, NS, Canada.

Tim Cyr (T)

Nova Scotia Department of Health and Wellness, Halifax, NS, Canada.

Sonny Dhanani (S)

Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AB, Canada.
Division of Critical Care, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.

Mélanie Dieudé (M)

Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AB, Canada.
Faculty of Medicine, University of Montréal, Montréal, QC, Canada.

Jade S Dirk (JS)

Department of Research & Innovation, Nova Scotia Health Authority, Halifax, NS, Canada.

David Hartell (D)

Canadian Blood Services, Ottawa, ON, Canada.

Cynthia Isenor (C)

Legacy of Life and Critical Care Organ Donation, Nova Scotia Health Authority, Halifax, NS, Canada.
Central Zone and Policy and Planning Critical Care Program, Nova Scotia Health Authority, Halifax, NS, Canada.

Lee James (L)

Canadian Blood Services, Vancouver, BC, Canada.

Amanda Lucas (A)

Department of Health Research Methodology Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Chelsea Patriquin (C)

Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AB, Canada.

Christy Simpson (C)

Canadian Blood Services, Ottawa, ON, Canada.
Department of Bioethics, Dalhousie University, Halifax, NS, Canada.

Victoria L Sullivan (VL)

Central Zone, Nova Scotia Health Authority, Halifax, NS, Canada.

Karthik K Tennankore (KK)

Department of Medicine, Dalhousie University, Halifax, NS, Canada.
Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada.

Jennifer Thurlow (J)

Department of Research & Innovation, Nova Scotia Health Authority, Halifax, NS, Canada.

Robin Urquhart (R)

Department of Research & Innovation, Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Surgery, Dalhousie University, Halifax, NS, Canada.

Hans Vorster (H)

Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AB, Canada.

Stephen D Beed (SD)

Legacy of Life and Critical Care Organ Donation, Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Critical Care, Dalhousie University, Halifax, NS, Canada.

Classifications MeSH